Competition escalates between the "Medical ChatGPT": Billion-dollar disputes intensified by two filed lawsuits
In the rapidly evolving world of artificial intelligence (AI), two major players, Doximity and OpenEvidence, are currently embroiled in a series of lawsuits that could set new legal precedents for disputes over trade secrets.
Doximity, a digital platform for medical professionals, and OpenEvidence, a startup backed by Sequoia, have found themselves at odds over allegations of trade secret theft and defamation. The dispute initially started when OpenEvidence accused Doximity of stealing healthcare AI code, a claim that Doximity has since disputed.
The US Department of Justice and other US judicial bodies, along with tech giants like Google, have also been involved in lawsuits concerning privacy violations and misuse of data in AI and online advertising contexts. Meanwhile, AI firm Anthropic faces a class-action lawsuit over unauthorized use of authors' books, offering compensation.
The lawsuits between Doximity and OpenEvidence are significant because they involve complex issues of AI technology and trade secrets. The outcome of these legal battles could shape the future of how such disputes are handled in the age of AI.
As the legal proceedings continue, it is important to note that both Doximity and OpenEvidence have integrated external subscription services into their websites. For instance, Doximity uses "Piano" for its subscription service.
In terms of data processing, users who agree to enable content on the websites of both Doximity and OpenEvidence may have usage profiles created and enriched, even outside the European Economic Area (EEA). Consent for data processing, including transfer of certain personal data to third countries, including the USA, is given when enabling content on the website, pursuant to Art 49 (1) (a) GDPR.
Users can find more details on data processing in the privacy policy and privacy statement, available at the footer of the offer at any time. Consent can be withdrawn at any time via the "Withdraw Tracking" link in the footer of the offer.
In addition to the trade secret dispute, Doximity has also sued OpenEvidence for defamation. The details of this lawsuit have not been disclosed publicly, and both parties are yet to comment on the matter.
As the legal battles between Doximity and OpenEvidence unfold, it is clear that the stakes are high, not just for these two companies, but for the entire AI industry. The outcome of these lawsuits could have far-reaching implications for how AI companies protect and handle trade secrets, and how they are held accountable for their actions.
Stay tuned for updates as this story develops.
Read also:
- User Data Analysis on Epic Games Store
- Rachel Reeves conducts a discussion with Scott Bessent and financial executives, focusing on investment matters
- Hyundai accelerates production plans: Introducing 7 new N models, aiming for a sales figure of 100,000 units by 2030.
- Yasa, an electric car engine producer, plans to broaden its operations.
